US 11707510
Nucleic acid-based botulinum neurotoxin for therapeutic use
granted A61KA61K31/7088A61K38/4893
Quick answer
US patent 11707510 (Nucleic acid-based botulinum neurotoxin for therapeutic use) held by PRECLINICS DISCOVERY GMBH expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECLINICS DISCOVERY GMBH
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7088, A61K38/4893, A61K8/606, A61P